Janus Henderson Group plc 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:34 am Sale | 2024-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -4,809,518 (Position Closed) | Filing |
| 2024-11-14 12:28 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 4,809,518 6.200% | 651,408 (+15.67%) | Filing |
| 2024-05-22 4:06 pm Purchase | 2024-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | JANUS HENDERSON GROUP PLC JHG | 4,158,110 5.300% | 4,158,110 (New Position) | Filing |